This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
pathway Info Card
Carnitine Shuttle
Information about Carnitine Shuttle: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Carnitine Shuttle
Most recent studies have shown that Carnitine Shuttle shares some biological mechanisms with carbon-utilization, energy-homeostasis, excretion, fatty-acid-beta-oxidation, fatty-acid-oxidation, gluconeogenesis, glyoxylate-cycle, muscle-contraction, oocyte-maturation, response-to-oxidative-stress, transport, tricarboxylic-acid-cycle, virulence.
Among the many pathways, these few ones have gauged particular interests from scientists studying Carnitine Shuttle, and have been seen in publications frequently: carbon-utilization, energy-homeostasis, excretion, fatty-acid-beta-oxidation, fatty-acid-oxidation, gluconeogenesis, glyoxylate-cycle, muscle-contraction, oocyte-maturation, response-to-oxidative-stress, transport, tricarboxylic-acid-cycle, virulence
Quite a number of genes have been found to play important roles in Carnitine Shuttle, such as ACOT7, ACSL1, ACSL6, ACSS2, CPT1A, CPT2, CRAT, GCG, GLYAT, INS, LPL, ME1, ME2, ME3, PGD, SLC22A5, SLC7A2, SST, TCN2. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this pathway. Plesae stay updated.